Categories: News

Update on full-year outlook for 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Company announcement no. 26 – 22
6 December 2022

Update on full-year outlook for 2022

Based on the financial performance during the first ten months of 2022, preliminary financial results for November 2022, and financial expectations for December 2022, NTG Nordic Transport Group A/S (“NTG”) adjusts its full-year outlook for 2022 as follows:

  • Revenue around DKK 10,200 million (previously DKK 9,700 – 10,200 million)
  • Adj. EBIT around DKK 750 million (previously DKK 700 – 750 million)

The full-year outlook for 2022 is adjusted based on indications of a stabilisation in certain markets during November and December of the year.

Additional information

For additional information, please contact:

Investor relations:
Christian D. Jakobsen, Group CFO                                    
+45 42 12 80 99
ir@ntg.com
Press:
Mathias Jensen-Vinstrup, Executive Vice President
+45 42 12 80 90
press@ntg.com

Attachment

Staff

Recent Posts

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

3 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

3 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

6 hours ago

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4…

8 hours ago

Healthcare Analytical Testing Services Market worth $12.48 billion by 2030 with 10.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market,…

9 hours ago